logo
US alcohol consumption at a record low as health warnings grow, survey finds

US alcohol consumption at a record low as health warnings grow, survey finds

The Guardian5 days ago
Alcohol consumption among adults in the US is at the lowest level on record, as most Americans, for the first time, view even moderate drinking as harmful, a new survey has found.
Pollster Gallup's latest Consumption Habits survey, conducted annually, showed that about 54% of Americans reported drinking alcohol, compared with 58% in 2024 and 62% in 2023.
The figure falls below the previous record low of 55% in 1958 in the nearly nine decades of such tracking by Gallup. And the figure appears not to be driven by people turning to alternatives, such as legal recreational cannabis, the researchers said.
Alcohol sales have been falling since the emergence of something of a national drinking binge during the Covid-19 pandemic, as inflation and interest rates stretch consumer wallets. Spirit makers now also face growing warnings from public health authorities who say drinking even small amounts of alcohol is associated with at least seven types of cancer.
A majority of Americans – 53% – say moderate drinking is bad for health, Gallup found, up from 45% last year.
Fewer US drinkers are consuming alcohol regularly, with a record-low 24% saying they had a drink in the previous day and 40% reporting more than a week since their last, the highest share since 2000, the survey found.
Average intake over the past seven days fell to 2.8 drinks, the lowest since 1996 and down from 3.8 a year ago, far below the 2003 peak of 5.1 drinks per week, the reports showed.
'The decline in alcohol consumption does not appear to be caused by people shifting to other mood-altering substances, in particular, recreational marijuana, which is now legal in about half of US states,' Lydia Saad, Gallup's director of social research, said.
Gallup has tracked Americans' drinking behavior since 1939 and their views of the health implications of moderate drinking since 2001.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bausch + Lomb board members resign after Icahn agreement ends
Bausch + Lomb board members resign after Icahn agreement ends

Reuters

time6 minutes ago

  • Reuters

Bausch + Lomb board members resign after Icahn agreement ends

Aug 18 (Reuters) - Bausch + Lomb ( opens new tab said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire Carl Icahn and some of his affiliates. The agreement, dated June 21, 2022, ended after the Icahn group's net long position in Bausch Health Companies ( opens new tab, Bausch + Lomb's parent, fell below the required threshold. On Friday, Bausch Health said Paulson Capital, along with certain affiliates and managed funds, increased their position in the company and acquired about 34.7 million common shares previously held by the Icahn Group. In April, Carl Icahn had built an economic interest covering about 34% of Bausch Health's shares.

Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him
Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him

Daily Mail​

timean hour ago

  • Daily Mail​

Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him

Philadelphia Phillies pitcher Zack Wheeler has undergone a successful thrombolysis procedure, which removed a blood clot from his upper body on Monday, the team announced. The procedure was performed by Dr. Paul DiMuzio at Thomas Jefferson University Hospital in downtown Philadelphia. Wheeler's timeline to return to the field and treatment for the procedure has yet to be determined.

CVS insurance policies don't provide opioid coverage, top Delaware court rules
CVS insurance policies don't provide opioid coverage, top Delaware court rules

Reuters

time2 hours ago

  • Reuters

CVS insurance policies don't provide opioid coverage, top Delaware court rules

Aug 18 (Reuters) - CVS Health (CVS.N), opens new tab is not entitled to coverage from insurers, including AIG (AIG.N), opens new tab and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday. The Delaware Supreme Court concluded that governments, hospitals, doctors and benefit plans that sued CVS sought damages for economic losses, not individualized "bodily injury" or "property damage" covered by CVS's general liability policies. It also rejected the argument that CVS' $5 billion nationwide settlement of opioid claims in November 2022 showed that the pharmacy chain and benefits manager had been sued for bodily injury. "The national settlement agreement funds expenses in response to the opioid crisis at-large, but it does not change the fact that the underlying lawsuits do not seek specific damages tied to individualized injuries," Chief Justice Collins Seitz wrote for a unanimous court. CVS said it disagreed with the decision, and that it trains its pharmacists to make the best decisions on patients' behalf and in compliance with the law. AIG, Chubb and their lawyers did not immediately respond to requests for comment. Many insurers have been sued by pharmacy chains, drugmakers and others seeking coverage for opioid-related bills. Chains had long argued they were merely filling doctors' prescriptions, but critics said the large quantities being dispensed and the potential for diversion were red flags. Walgreens (WBA.O), opens new tab and Walmart, opens new tab(WMT.N), opens new tab agreed to pay more than $8 billion in similar settlements. CVS, based in Woonsocket, Rhode Island, had been appealing two Delaware Superior Court decisions denying insurance coverage in more than 2,300 lawsuits, according to Monday's decision. Governments complained about increased spending to treat opioid addiction, hospitals reported strains on their health systems, and third-party payors such as employee benefit funds cited costs of prescription purchases and addiction treatment. The Delaware Supreme Court ruled in Chubb's favor in a similar case involving Rite Aid in 2022. CVS claimed that its own policies offered broader coverage, but the court found the policies "similar in all material respects" to Rite Aid's. The case is In re CVS Opioid Insurance Litigation, Delaware Supreme Court, No. 482.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store